Literature DB >> 15567028

Sequence polymorphism in the E3 7.7K ORF of subspecies B1 human adenoviruses.

A E Kajon1, W Xu, D D Erdman.   

Abstract

Sequences corresponding to the 7.7K open-reading frame (ORF) of the E3 region of subspecies B1 adenoviruses (Ads) were compared with prototype strains of Ad3, Ad7, Ad16, Ad21, and Ad50 and field isolates representing a variety of genome restriction types of Ad3 and Ad7 to better assess the extent of genetic variation in this intriguing region of the viral genome encoding a product whose function is still unknown. Alignment of 55 species B1 Ad sequences revealed a marked polymorphism in the 7.7K ORF and allowed the identification of eight distinct sequence profiles (SPs) characterized by (1) deletions that retain or change the reading frame, (2) single-base mutations (SBMs) that change the start codon (ATG to ATT or ATC), and (3) other SBMs. mRNAs of expected size for the observed sequence polymorphisms were identified by RT-PCR from DNAse I-treated total RNA extracts of infected cells. Predicted proteins ranged from 0 to 94 amino acids corresponding to molecular masses of 0-11 K. Together with the hypervariable regions of the hexon gene, the E3 7.7K ORF appears to be another area of the Ad genome in which genetic diversity may be generated by illegitimate recombination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15567028     DOI: 10.1016/j.virusres.2004.06.005

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

1.  Open reading frame E3-10.9K of subspecies B1 human adenoviruses encodes a family of late orthologous proteins that vary in their predicted structural features and subcellular localization.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease.

Authors:  Anjan Purkayastha; Jing Su; John McGraw; Susan E Ditty; Ted L Hadfield; Jason Seto; Kevin L Russell; Clark Tibbetts; Donald Seto
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain.

Authors:  Helena Rebelo-de-Andrade; Cristiana Pereira; Marta Gíria; Ema Prudêncio; Maria João Brito; Etelvina Calé; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

4.  Complete genome analysis of a novel E3-partial-deleted human adenovirus type 7 strain isolated in Southern China.

Authors:  Xiaobo Su; Xingui Tian; Qiwei Zhang; Haitao Li; Xiao Li; Huiying Sheng; Youshao Wang; Houbo Wu; Rong Zhou
Journal:  Virol J       Date:  2011-03-04       Impact factor: 4.099

5.  Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery.

Authors:  Jason Seto; Michael P Walsh; Padmanabhan Mahadevan; Qiwei Zhang; Donald Seto
Journal:  Viruses       Date:  2010-01-06       Impact factor: 5.818

6.  The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3.

Authors:  Dominique Sirena; Zsolt Ruzsics; Walter Schaffner; Urs F Greber; Silvio Hemmi
Journal:  Virology       Date:  2005-09-16       Impact factor: 3.616

7.  Human mastadenovirus-B (HAdV-B)-specific E3-CR1β and E3-CR1γ glycoproteins interact with each other and localize at the plasma membrane of non-polarized airway epithelial cells.

Authors:  Poornima Kotha Lakshmi Narayan; Adriana E Kajon
Journal:  Virology       Date:  2020-04-15       Impact factor: 3.616

8.  No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  BMC Res Notes       Date:  2012-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.